MedPath

Cefazolin

Cefazolin for Injection, USP

Approved
Approval ID

62441488-fc97-4535-a249-4485fb075022

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 8, 2020

Manufacturers
FDA

Hospira, Inc

DUNS: 141588017

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Cefazolin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0409-2585
Application NumberANDA065345
Product Classification
M
Marketing Category
C73584
G
Generic Name
Cefazolin
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJune 15, 2017
FDA Product Classification

INGREDIENTS (1)

CEFAZOLIN SODIUMActive
Quantity: 1 g in 1 1
Code: P380M0454Z
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Cefazolin - FDA Drug Approval Details